Moreover, CD279 mRNA level increased in CD4+ T cells in samples from all but one healthy control (Fig. 4h), and in CD8+ T cells and NK cells from both healthy controls and HNSCC patients in response to IFNα treatment (Fig. 4i, j). Here, CD4 is linked to head and neck squamous cell carcinoma.